Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 109

1.

Bisphosphonate-induced osteopetrosis: novel bone modeling defects, metaphyseal osteopenia, and osteosclerosis fractures after drug exposure ceases.

Whyte MP, McAlister WH, Novack DV, Clements KL, Schoenecker PL, Wenkert D.

J Bone Miner Res. 2008 Oct;23(10):1698-707. doi: 10.1359/jbmr.080511.

2.

Can bisphosphonate treatment be stopped in a growing child with skeletal fragility?

Ward KA, Adams JE, Freemont TJ, Mughal MZ.

Osteoporos Int. 2007 Aug;18(8):1137-40. Epub 2007 Feb 6.

PMID:
17279467
3.

Rapid skeletal turnover in a radiographic mimic of osteopetrosis.

Whyte MP, Madson KL, Mumm S, McAlister WH, Novack DV, Blair JC, Helliwell TR, Stolina M, Abernethy LJ, Shaw NJ.

J Bone Miner Res. 2014 Dec;29(12):2601-9. doi: 10.1002/jbmr.2289.

4.

Severe osteopenia in a young boy with Kostmann's congenital neutropenia treated with granulocyte colony-stimulating factor: suggested therapeutic approach.

Sekhar RV, Culbert S, Hoots WK, Klein MJ, Zietz H, Vassilopoulou-Sellin R.

Pediatrics. 2001 Sep;108(3):E54.

PMID:
11533372
5.

Dysosteosclerosis presents as an "osteoclast-poor" form of osteopetrosis: comprehensive investigation of a 3-year-old girl and literature review.

Whyte MP, Wenkert D, McAlister WH, Novack DV, Nenninger AR, Zhang X, Huskey M, Mumm S.

J Bone Miner Res. 2010 Nov;25(11):2527-39. doi: 10.1002/jbmr.131. Review.

6.

Osteoporosis treatment: quo vadis? (A brief overview).

Frost HM.

Medicina (B Aires). 1997;57 Suppl 1:119-26. Review.

PMID:
9567365
7.

[Effects of bisphosphonates on the mechanical efficiency of normal and osteopenic bones].

Ferretti JL, Cointry GR, Capozza RF, Mondelo N, Peluffo V, Chiappe A, Meta M, Alippi RM.

Medicina (B Aires). 1997;57 Suppl 1:83-92. Spanish.

PMID:
9567360
8.

Adult osteosclerosis.

Evans RA, Hughes WG, Dunstan CR, Lennon WP, Kohan L, Hills E, Wong SY.

Metab Bone Dis Relat Res. 1983-1984;5(3):111-7.

PMID:
6676625
9.
10.
11.

Congenital erythropoietic porphyria: skeletal manifestations and effect of pamidronate treatment.

Oliveri MB, Mautalen C, Mega M, Rossi E.

Bone. 1994 Jan-Feb;15(1):101-4.

PMID:
8024843
12.

Endemic fluorosis of the skeleton: radiographic features in 127 patients.

Wang Y, Yin Y, Gilula LA, Wilson AJ.

AJR Am J Roentgenol. 1994 Jan;162(1):93-8.

PMID:
8273699
13.
14.

High bone mineral density in pycnodysostotic patients with a novel mutation in the propeptide of cathepsin K.

Schilling AF, Mülhausen C, Lehmann W, Santer R, Schinke T, Rueger JM, Amling M.

Osteoporos Int. 2007 May;18(5):659-69. Epub 2007 Jan 6.

PMID:
17206399
15.
16.

Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment.

Marx RE, Sawatari Y, Fortin M, Broumand V.

J Oral Maxillofac Surg. 2005 Nov;63(11):1567-75.

PMID:
16243172
17.

The incidence of osteopenia and osteoporosis in women with hip osteoarthritis scheduled for cementless total joint replacement.

Mäkinen TJ, Alm JJ, Laine H, Svedström E, Aro HT.

Bone. 2007 Apr;40(4):1041-7. Epub 2007 Jan 17.

PMID:
17239668
18.

Decreased lumbar spine bone mass and low bone turnover in children and adolescents with insulin dependent diabetes mellitus followed longitudinally.

Gunczler P, Lanes R, Paz-Martinez V, Martins R, Esaa S, Colmenares V, Weisinger JR.

J Pediatr Endocrinol Metab. 1998;11(3):413-9.

PMID:
11517957
19.

The use of pamidronate in three children with renal disease.

Sellers E, Sharma A, Rodd C.

Pediatr Nephrol. 1998 Nov;12(9):778-81.

PMID:
9874327
20.

Spinal irradiation impairs the osteo-anabolic effects of low-dose GH replacement in adults with childhood-onset GH deficiency.

Murray RD, Adams JE, Smethurst LE, Shalet SM.

Clin Endocrinol (Oxf). 2002 Feb;56(2):169-74.

PMID:
11874407

Supplemental Content

Support Center